A Blinded-Initiation Study of Medication Satisfaction in Subjects With Schizophrenia Treated With Paliperidone ER [extended release] After Suboptimal Response to Oral Risperidone.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Paliperidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 07 Jun 2017 Biomarkers information updated
- 20 Jun 2012 Planned number of patients changed from 132 to 150 as reported by European Clinical Trials Database.
- 06 Mar 2010 Results published in International Clinical Psychopharmacology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History